• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.

作者信息

Smith I E, Hedley D W, Powles T J, McElwain T J

出版信息

Cancer Treat Rep. 1978 Oct;62(10):1427-33.

PMID:709548
Abstract
摘要

相似文献

1
Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.长春地辛：一项治疗乳腺癌、恶性黑色素瘤及其他肿瘤的II期研究。
Cancer Treat Rep. 1978 Oct;62(10):1427-33.
2
Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study.新型长春花生物碱药物S12363治疗晚期恶性黑色素瘤的评估：一项II期研究。
Anticancer Res. 1993 Jan-Feb;13(1):31-2.
3
Vindesine for metastatic malignant melanoma. A phase II trial.长春地辛治疗转移性恶性黑色素瘤。一项II期试验。
Am J Clin Oncol. 1983 Oct;6(5):561-4.
4
Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors.氯脲霉素用于恶性黑色素瘤、乳腺癌及其他实体瘤的II期试验。
Cancer Treat Rep. 1982 May;66(5):1229-30.
5
Results of a phase II study of maytansine in patients with breast carcinoma and melanoma.
Cancer Treat Rep. 1979 Mar;63(3):507-9.
6
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.口服伊达比星（4-去甲氧基柔红霉素）治疗播散性恶性黑色素瘤患者的II期评估。
Cancer Treat Rep. 1986 Jul;70(7):911-2.
7
Phase II trial of carboplatin in advanced malignant melanoma.卡铂用于晚期恶性黑色素瘤的II期试验。
Cancer Treat Rep. 1987 Feb;71(2):171-2.
8
Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):1001-3.
9
Phase II study of vindesine infusion in visceral metastatic malignant melanoma.
Cancer Treat Rep. 1983 Sep;67(9):839-40.
10
Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
Cancer Treat Rev. 1980 Sep;7 Suppl 1:81-6. doi: 10.1016/s0305-7372(80)80013-2.

引用本文的文献

1
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.
Cancer Chemother Pharmacol. 1982;9(1):41-4. doi: 10.1007/BF00296760.
2
Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.小鼠淋巴母细胞长春新碱抗性和长春地辛抗性细胞系的体外建立及其交叉抗性模式和药物敏感性的表征。
Cancer Chemother Pharmacol. 1982;8(2):163-9. doi: 10.1007/BF00255477.
3
Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
Invest New Drugs. 1984;2(3):323-8. doi: 10.1007/BF00175385.
4
Chemotherapy of breast cancer.乳腺癌的化疗
Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.
5
Antitumor efficacy of seventeen anticancer drugs in human breast cancer xenograft (MX-1) transplanted in nude mice.十七种抗癌药物对移植于裸鼠的人乳腺癌异种移植瘤（MX-1）的抗肿瘤疗效。
Cancer Chemother Pharmacol. 1983;10(3):182-6. doi: 10.1007/BF00255758.
6
Antineoplastic drugs in 1990. A review (Part II).1990年的抗肿瘤药物。综述（第二部分）。
Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003.
7
Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.丝裂霉素C、长春地辛和美法仑联合化疗治疗难治性转移性乳腺癌。
J Cancer Res Clin Oncol. 1991;117(3):266-8. doi: 10.1007/BF01625437.
8
Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors.长春地辛治疗结直肠癌和食管癌的II期评估。
Cancer Chemother Pharmacol. 1979;2(4):263-6. doi: 10.1007/BF00257192.